Dabur India Limited operates within the Toilet preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Dabur India Limited with three other
cosmetics and toiletry producers in Asia:
sales of 96.31 billion Japanese Yen [US$858.08 million]
of which 59%
was Cosmetics Business),
Rohto Pharmaceutical Co., Ltd.
(154.60 billion Japanese Yen [US$1.38 billion]
of which 63%
was Operating segment-Japan), and
Rizap Group Inc
based in Japan
(95.30 billion Japanese Yen [US$849.12 million]
of which 40%
was Health & Beauty-Related Businesses).
During the year ended March of 2017, sales at
Dabur India Limited were 77.01 billion Indian Rupees (US$1.18 billion).
decrease of 8.9%
versus 2016, when the company's sales were 84.54 billion Indian Rupees.
Contributing to the drop in overall sales was the 17.2% decline
in Others, from 1.37 billion Indian Rupees to 1.14 billion Indian Rupees.
There were also decreases in sales in
Consumer Care Business (down 10.7% to 63.29 billion Indian Rupees)
However, these declines were partially offset by the increase in sales of
Foods (up 1.7% to 11.14 billion Indian Rupees)
Retail (up 6.4% to 1.23 billion Indian Rupees)